TREAMENT OF EARLY AGE MANIA (TEAM)

早期躁狂症的治疗（团队）

• 批准号: 7376182
• 负责人: PARAMJIT T. JOSHI
• 金额: $ 6.81万
• 依托单位: CHILDREN'S RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7376182
• 关键词: TREAMENT; EARLY; AGE; MANIA; TEAM

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The overall aim of this study is to perform a collaborative, multisite psychopharmacology effectiveness study of 6.0-15 years old (N=540) who have DSM-IV (mania or mixed phase) or mania. The specific aims of this protocol are: (1) To investigate the effectivness of lithium, valproate and resperidone as monotherapy and as add-on agents for childhood BP-1 (manic or mixed phase) disorder (2) To pilot a complex, multistrata, adaptive strategy design (3) to explore the effects of psychosocial factors on discontinuation, compliance and outcome.

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子弹和调查员（PI）可能已经从其他NIH来源获得了主要资金，因此可以在其他清晰的条目中代表。列出的机构适用于该中心，这不一定是调查员的机构。这项研究的总体目的是对具有DSM-IV（躁狂症或混合阶段）或躁狂症的6.0-15岁（n = 540）的6.0-15岁（n = 540）进行协作，多潜在的心理药理学有效性研究。该方案的具体目的是：（1）研究锂，丙丙酸酯和腐烂的酮作为单一疗法的有效性，并作为儿童期BP-1（躁狂或混合相）疾病（2）的附加代理（以实现复杂的，多发性的，多发性，适应性策略设计（3）的影响，以探索心理社会因素对不适应性和成果的影响。